Prolonged Suppressive Effects of Periodontitis on Salivary TFF3 Production

VR, D. R, Sayed AJ. Gingivitis and periodontitis among Indian patients diagnosed using trefoil factor 3

Recently there has been an increased interest on the identifying and preventing the disease with profuse biomarkers. There are very few studies done in understanding the relationship of TFF3 levels in the diseased condition. Therefore, it is of interest to determine effect of non-surgical periodontal therapy on trefoil factor levels in patients with gingivitis and periodontitis. Study sample consisting of 40 subjects of which 20 with gingivitis and 20 with moderate chronic periodontitis were included. The clinical parameters assessed were gingival index, Plaque index, and Probing Depth and Clinical attachment levels. Enzyme linked immunosorbent assay was used to evaluate Serum Trefoil factor 3 (TFF3). Intra group comparisons in gingivitis and periodontitis group have shown that all clinical and biochemical parameters have significantly reduced from base line to 3 months. Increased serum TFF3 concentrations were observed after non-surgical periodontal therapy in both gingivitis and chronic periodontitis group (p<0.001). In conclusion clinical and biochemical analysis of serum TFF3 revealed its influence on periodontal disease activity. Elevated serum Trefoil factor 3 levels showed a strong association with decrease in clinical parameters taken after the therapy.

Salivary IL-17 and IL-10 as Potential Diagnostic Biomarkers of Different Stages of Periodontitis in Smoker and Nonsmoker Patients

OBJECTIVES

 The gold standard in the field of periodontal research currently is to find a valid biomarker that can reliably be used for diagnosing periodontal diseases. Given the limitations of the current diagnostic tools that stall to predict susceptible individuals and determine whether active tissue destruction is occurring, there is an increased urge to develop alternative diagnostic techniques that would compensate for the problems inherited in these available methods, such as measuring levels of biomarkers present in oral fluids such as saliva; so the aim of this study was to determine the diagnostic potential of interleukin-17 (IL-17) and IL-10 to differentiate periodontal health from smoker and nonsmoker periodontitis, and to differentiate among different stages (severities) of periodontitis.

MATERIALS AND METHODS

 An observational case-control study was performed on 175 systemically healthy participants grouped into healthy as controls and periodontitis as cases. Periodontitis cases were divided according to the severity into stages I, II, and III, and each of the stages was further subdivided into smokers and nonsmokers patients. Unstimulated saliva samples were collected, clinical parameters were recorded, and salivary levels were assayed using enzyme-linked immunosorbent assay.

RESULTS

 Elevated levels of IL-17 and IL-10 were associated with stage I and II compared with the healthy controls. However, a significant decrease in stage III was observed compared with the control group for both biomarkers.

CONCLUSION

 Salivary IL-17 and IL-10 might be useful for distinguishing periodontal health from periodontitis; however, further research is needed to substantiate their use as potential biomarkers for the diagnosis of periodontitis.

The trefoil factor family 1 (TFF-1) and 3 (TFF-3) are upregulated in the saliva, gingival crevicular fluid and serum of periodontitis patients

OBJECTIVE

This study aimed to investigate the levels of trefoil factor family (TFF)-1, TFF-3 and interleukin (IL)-1β in gingival crevicular fluid (GCF), saliva and serum of patients with gingivitis, stage 3 periodontitis and healthy individuals.

MATERIALS AND METHODS

A total of 100 individuals consisting of 25 periodontally healthy, 25 gingivitis and 50 stage 3 periodontitis, were enrolled in the study. Clinical periodontal examinations were recorded and GCF, saliva and serum samples were obtained. TFF-1, TFF-3 and IL-1β were measured by ELISA.

RESULTS

TFF-1 and TFF-3 levels in both GCF, saliva and serum were higher in periodontitis patients than healthy controls (p < .001) and gingivitis group (p < .01). The levels of these peptides in all biofluids were similar between gingivitis and healthy control groups (p > .05). GCF, saliva and serum IL-1β levels were also higher in periodontitis patients than the controls (p < .01). Periodontitis patients had elevated GCF and saliva IL-β levels than gingivitis group (p < .001).

CONCLUSION

Elevated TFF-1 and TFF-3 levels both locally and systemically in periodontitis in parallel to increased IL-1β levels might suggest that these peptides are involved in host response during the periodontal tissue destruction.